This review seeks to describe the use and effects of the drug modafinil. Specifically,\nit presents the research of the impact of modafinil for people with diagnosis\nand experience of schizophrenia. Recent reviews have shown that modafinil\ncan positively impact on cognitive function in people with a diagnosis of\nschizophrenia. There is emerging evidence for the positive impact of modafinil\non negative symptoms, functioning, quality of life, wellbeing, and body mass\nindex (BMI) for people with schizophrenia. Compared to other central nerve\nstimulant (CNS) drugs, modafinil has a low risk of dependency and few negative\nside effects; but there are risks of triggering positive symptoms in schizophrenia.\nA well designed and sufficiently large randomised control trial is\nrequired to test the potential of the impact of modafinil in the lives of people\nwith a diagnosis of schizophrenia. Future research should report participant�s\nperspective of the value of modafinil connected to what concerns them and\nwhat they want to achieve in their lives.
Loading....